No Data
Shanghai Titan Scientific Co.,Ltd. (688133.SH): DeepSeek has not been deployed yet.
On March 10, Glonghui reported that Shanghai Titan Scientific Co.,Ltd. (688133.SH) stated on the investor interaction platform that the company has not yet deployed DeepSeek. The company is paying attention to the application of new technologies in the industry and is also planning related initiatives. If future deployment and integration occur, they will primarily be used to improve internal work efficiency. The company is currently conducting a cautious evaluation considering various factors such as business needs and cost-effectiveness. If future progress touches upon relevant regulations and requirements, the company will promptly disclose related information to the majority of investors.
Titan Technology: Titan Technology 2024 Annual Performance Report Announcement
Titan Technology 2024 Annual Results Report Announcement
The new electronic-grade ultra-pure water product developed by a subsidiary of Shanghai Titan Scientific Co., Ltd. has successfully passed internal testing.
Shanghai Titan Scientific Co., Ltd. (688133.SH) announced that its subsidiary Anhui Tiandi High-Purity Solvent Co., Ltd. (referred to as "subsidiary...")
2024 Annual Results Pre-Reduction Announcement
Shanghai Titan Scientific Co.,Ltd. (688133.SH): The net income for 2024 is expected to decrease by 80.71% to 86.91%.
On January 24, Glonghui reported that Shanghai Titan Scientific Co., Ltd. (688133.SH) announced a profit warning for its 2024 annual performance, expecting the net income attributable to the parent company to be between 9.5 million RMB and 14 million RMB, a year-on-year decrease of 80.71% to 86.91%. It is anticipated that the net income attributable to the parent company after excluding non-recurring gains and losses will be between 5.2 million RMB and 7.8 million RMB, a year-on-year decrease of 84.82% to 89.88%. In 2024, the company faces a lack of incremental demand from downstream, as customers are focused on cost reduction and efficiency improvement, resulting in continued pressure in the industry.
Shanghai Titan Scientific (SHSE:688133) Could Be Struggling To Allocate Capital
